Partial Splenic Embolization in the Management of Thalassemia

  • C. Politis
  • D. G. Spigos


Thalassemia becomes complicated by hypersplenism in any patient at some time during the clinical course, and this leads to a progressive increase of transfusional requirements [1]. Splenectomy usually results in a substantial decline of transfusional needs. Unfortunately, the effectiveness of splenectomy is not easily predictable. About 1 year after the operation, a small proportion of splenectomized thalassemic patients have again increased transfusional needs. Furthermore, the risk of overwhelming postsplenectomy infection is higher in these patients than in many other groups of splenectomized individuals [2, 3]. Hypoxemia with pulmonary artery embolism has also been reported after splenectomy in thalassemic patients [4].


Thalassemic Patient Splenic Abscess Thalassemia Intermedium Partial Splenic Embolization Splenic Vein Thrombosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Modell B, Berdoukas V (1984) The clinical approach to thalssemia. Grune and Stratton, New YorkGoogle Scholar
  2. 2.
    Smith CH, Erlandson ME, Stem G, Hilgartner MW (1964) Postsplenectomy infection in Cooley’s anemia. Ann NY Acad Sci 119: 748–757PubMedCrossRefGoogle Scholar
  3. 3.
    Eraklis AJ, Kevy SV, Diamond LK, Cross RE (1967) Hazard of overwhelming infection after splenectomy in childhood. N Engl J Med 276: 1225–1229PubMedCrossRefGoogle Scholar
  4. 4.
    Fucharoen S (1981) Hypoxaemia and the effect of aspirin in thalassemia. Southeast Asian J Trop Med Public Health 12: 90–93PubMedGoogle Scholar
  5. 5.
    Politis C, Spigos DG, Georgiopoulou P, Vrettou H, Economidou J, Germenis A, Richardson C, Papaevangelou G (1987) Partial splenic embolization for hypersplenism of thalassemia major. Five year follow-up. Br Med J 294: 665–667CrossRefGoogle Scholar
  6. 6.
    Girot R, Revillon Y, Barritault L, Gire R, Beringer A, Boiteux F(1984) Hypersplenisme de la thalassémie majeure. Traitement par désartérialisation partielle de la rate. Résultats préliminaires à propos de 5 cas. Presse Med 13: 1881Google Scholar
  7. 7.
    Mozes MF, Spigos DG, Pollak R, Abejo R, Pavel DG, Tan WS, Jonasson O (1984) Partial splenic embolization, an alternative to splenectomy results of a prospective randomized study. Surgery 96: 694–702PubMedGoogle Scholar
  8. 8.
    Maddison FE (1973) Embolic therapy of hypersplenism. Invest Radiol 8: 280–281CrossRefGoogle Scholar
  9. 9.
    Spigos DG, Jonasson O, Mozes M, Capek V (1979) Partial splenic embolization in the treatment of hypersplenism. Am J Radiol 132: 777–782Google Scholar
  10. 10.
    Germenis A, Dimitriou P, Kasfiki A, Antipas SE (1986) Kinetics of heat-damaged homologous red blood cells in patients with homozygous flthalassemia in relation to blood transfusion. Scand J Haematol 36: 450–456PubMedCrossRefGoogle Scholar
  11. 11.
    Germenis A, Antipas SE, Dimitriou P, Politis C, Spigos DG (1988) Assessment of splenic and RES function of patients with thalassemia major long after partial splenic embolisation: In vivo clearance study. Eur J Hematol 40: 466–472CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • C. Politis
  • D. G. Spigos

There are no affiliations available

Personalised recommendations